• SPX
  • $5,992.99
  • 0.33 %
  • $19.89
  • DJI
  • $43,988.99
  • 0.59 %
  • $259.65
  • N225
  • $39,500.37
  • 0.3 %
  • $118.96
  • FTSE
  • $8,072.39
  • -0.84 %
  • -$68.35
  • IXIC
  • $19,286.78
  • 0.09 %
  • $17.32
NeuroMetrix, Inc. (NURO) Stock Price, News & Analysis

NeuroMetrix, Inc. (NURO) Stock Price, News & Analysis

Currency in USD Disclaimer

$3.72

-$0.12

(-3.13%)

Day's range
$3.64
Day's range
$3.84
50-day range
$3.22
Day's range
$4.73
  • Country: US
  • ISIN: US6412558800
52 wk range
$2.66
Day's range
$4.73
  • CEO: Dr. Shai N. Gozani M.D., Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -14.12
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (NURO)
  • Company NeuroMetrix, Inc.
  • Price $3.72
  • Changes Percentage (-3.13%)
  • Change -$0.12
  • Day Low $3.64
  • Day High $3.84
  • Year High $4.73

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

  • Last Earnings 03/14/2007
  • Ex-Dividend for 5/16 Dividend 03/28/2007
  • Dividend Payable 04/13/2007
  • Today N/A
  • Next Earnings (Estimated) 01/23/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$6.30
  • Trailing P/E Ratio -0.61
  • Forward P/E Ratio -0.61
  • P/E Growth -0.61
  • Net Income $-6,529,487

Income Statement

Quarterly

Annual

Latest News of NURO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.